Pyrido[2,3-d]pyrimidine derivatives
US4889859A · kind A · utility
21Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 1988 |
| Grant date | Dec 26, 1989 |
| Priority date | — |
| Expiry date | Feb 5, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Derivatives of N-[2-(5,6,7,8-tetrahydropyrido-[2,3-d]pyrimidin-6-yl)-alkyl]benzoyl-L-glut amic acid are antineoplastic agents. A typical embodiment is N-(2-fluoro-4-[2-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido-[2,3-d]pyrimi din-6-yl)ethyl]benzoyl)-L-glutamic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.